Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Domino, Marisa Elena
and
Swartz, Marvin S.
2008.
Special Section on Implications of CATIE: Who Are the New Users of Antipsychotic Medications?.
Psychiatric Services,
Vol. 59,
Issue. 5,
p.
507.
Kake, Tai R.
Arnold, Richard
and
Ellis, Pete
2008.
Estimating the Prevalence of Schizophrenia Among New Zealand Māori: A Capture–Recapture Approach.
Australian & New Zealand Journal of Psychiatry,
Vol. 42,
Issue. 11,
p.
941.
Pletnikov, Mikhail V.
2009.
Genetic Models of Schizophrenia.
Vol. 179,
Issue. ,
p.
35.
Zauszniewski, Jaclene A.
Bekhet, Abir K.
and
Suresky, M. Jane
2009.
Effects on Resilience of Women Family Caregivers of Adults With Serious Mental Illness: The Role of Positive Cognitions.
Archives of Psychiatric Nursing,
Vol. 23,
Issue. 6,
p.
412.
Yu, Andrew P.
Atanasov, Pavel
Ben-Hamadi, Rym
Birnbaum, Howard
Stensland, Michael D.
and
Philips, Glenn
2009.
Resource Utilization and Costs of Schizophrenia Patients Treated with Olanzapine versus Quetiapine in a Medicaid Population.
Value in Health,
Vol. 12,
Issue. 5,
p.
708.
Yu, Andrew P.
Ben-Hamadi, Rym
Birnbaum, Howard G.
Atanasov, Pavel
Stensland, Michael D.
and
Philips, Glenn
2009.
Comparing the treatment patterns of patients with schizophrenia treated with olanzapine and quetiapine in the Pennsylvania Medicaid population.
Current Medical Research and Opinion,
Vol. 25,
Issue. 3,
p.
755.
Jablensky, Assen
Kirkbride, James B.
and
Jones, Peter B.
2010.
Schizophrenia.
p.
185.
Kirson, Noam Y.
Ivanova, Jasmina I.
Birnbaum, Howard G.
Wei, Robert
Kantor, Evan
Amy Puenpatom, R.
Ben-Joseph, Rami H.
and
Summers, Kent H.
2010.
Descriptive analysis of Medicaid patients with postherpetic neuralgia treated with lidocaine patch 5%.
Journal of Medical Economics,
Vol. 13,
Issue. 3,
p.
472.
Gregory, Virgil L.
2010.
Cognitive-Behavioral Therapy for Schizophrenia: Applications to Social Work Practice.
Social Work in Mental Health,
Vol. 8,
Issue. 2,
p.
140.
Lu, Yisheng
Yin, Dong-Min
Xiong, Wen-Cheng
and
Mei, Lin
2011.
Animal Models of Schizophrenia and Related Disorders.
Vol. 59,
Issue. ,
p.
261.
Robertson, Holly R.
and
Feng, Guoping
2011.
Annual Research Review: Transgenic mouse models of childhood‐onset psychiatric disorders.
Journal of Child Psychology and Psychiatry,
Vol. 52,
Issue. 4,
p.
442.
Basu, Anirban
Jena, Anupam B.
and
Philipson, Tomas J.
2011.
The impact of comparative effectiveness research on health and health care spending.
Journal of Health Economics,
Vol. 30,
Issue. 4,
p.
695.
Hansen, Richard A.
Maciejewski, Matthew
Yu-Isenberg, Kristina
and
Farley, Joel F.
2012.
Adherence to Antipsychotics and Cardiometabolic Medication: Association With Health Care Utilization and Costs.
Psychiatric Services,
Vol. 63,
Issue. 9,
p.
920.
Lafeuille, Marie-Hélène
Gravel, Jonathan
Lefebvre, Patrick
Fastenau, John
Muser, Erik
Doshi, Dilesh
and
Duh, Mei Sheng
2013.
Patterns of relapse and associated cost burden in schizophrenia patients receiving atypical antipsychotics.
Journal of Medical Economics,
Vol. 16,
Issue. 11,
p.
1290.
Rajagopalan, Krithika
O’Day, Ken
Meyer, Kellie
Pikalov, Andrei
and
Loebel, Antony
2013.
Annual cost of relapses and relapse-related hospitalizations in adults with schizophrenia: results from a 12-month, double-blind, comparative study of lurasidone vs quetiapine extended-release.
Journal of Medical Economics,
Vol. 16,
Issue. 8,
p.
987.
Rajagopalan, Krithika
Hassan, Mariam
O’Day, Ken
Meyer, Kellie
and
Grossman, Fred
2013.
Cost-effectiveness of lurasidone vs aripiprazole among patients with schizophrenia who have previously failed on an atypical antipsychotic: an indirect comparison of outcomes from clinical trial data.
Journal of Medical Economics,
Vol. 16,
Issue. 7,
p.
951.
Farasatpour, Mishel
Janardhan, Radhakrishna
Williams, Campbell D.
Margenthaler, Julie A.
Virgo, Katherine S.
and
Johnson, Frank E.
2013.
Breast cancer in patients with schizophrenia.
The American Journal of Surgery,
Vol. 206,
Issue. 5,
p.
798.
Smith, Gary
2014.
Estimating the population attributable fraction for schizophrenia when Toxoplasma gondii is assumed absent in human populations.
Preventive Veterinary Medicine,
Vol. 117,
Issue. 3-4,
p.
425.
Wang, Chi-Chuan
Maciejewski, Matthew L.
Rao, Jaya K.
Sheitman, Brian B.
Sleath, Betsy L.
and
Farley, Joel F.
2014.
Examining the Relationship Between Adjunctive Psychotherapy Use and Antipsychotic Persistence and Hospitalization.
Administration and Policy in Mental Health and Mental Health Services Research,
Vol. 41,
Issue. 5,
p.
598.
Jörgensen, Lena
Allebeck, Peter
and
Dalman, Christina
2014.
Prevalence of psychoses in Stockholm County—A population-based study using comprehensive healthcare registers.
Nordic Journal of Psychiatry,
Vol. 68,
Issue. 1,
p.
60.